Cargando…
Response to Vaccination Against SARS-CoV-2 in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Renal Involvement
BACKGROUND: Patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) present with multisystem disease including renal impairment. The treatment for AAV involves a high burden of immunosuppression. Patients with renal involvement are treated especially intensively. As a...
Autores principales: | Carruthers, Jack E., Wells, James, Gupta, Arun, Kallon, Delordson, Cox, Amber, Pina, Neuza, Yaqoob, Muhammad Magdi, Rajakariar, Ravindra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811045/ https://www.ncbi.nlm.nih.gov/pubmed/35127773 http://dx.doi.org/10.3389/fmed.2021.817845 |
Ejemplares similares
-
Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis with Renal and Lung Involvement
por: Wong, Albert Hing, et al.
Publicado: (2022) -
Antineutrophilic Cytoplasmic Antibody Positive Vasculitis
Associated with Methimazole Use
por: Shikha, Deep, et al.
Publicado: (2015) -
Stress and Disease Onset in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Golemati, Christina V., et al.
Publicado: (2017) -
The role of mycophenolate in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis
por: Koukoulaki, Maria, et al.
Publicado: (2019) -
Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
por: Huizenga, Noah, et al.
Publicado: (2019)